Pavel O. Vorobyev - Concepedia

Author

Pavel O. Vorobyev

Also Known As

P O Vorobyev, P. O Vorobyev, P. O. Vorobyev, PO Vorobyev, Pavel O. Vorobyev, Pavel O. Vorob’yev, Pavel Vorobyev

Publications

141

Citations

H-Index

Concepts

All Affiliations

Pavel O. Vorobyev is an author at Engelhardt Institute of Molecular Biology specializing in glioma, virology, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	39
2	Immunology	3	3	39
3	Cell Biology	2	2	25
4	Natural Sciences	1	1	14
5	Biochemistry	1	1	14

Pavel O. Vorobyev

Publications

102

Citations

H-Index

Page 1

	Year	Citations
Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses Anastasiya V. Lipatova, Alesya V. Soboleva, Vladimir Gorshkov, Cancers	2021	30
Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models Yasmin Shakiba, Pavel O. Vorobyev, Victor Naumenko, Viruses	2023	17
Oncolytic therapy with recombinant vaccinia viruses targeting the interleukin-15 pathway elicits a synergistic response Yasmin Shakiba, Pavel O. Vorobyev, Gaukhar M. Yusubalieva, Molecular Therapy — Oncolytics	2023	16
2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus Pavel O. Vorobyev, Peter M. Chumakov, Natalia F. Zakirova, Cancers Synthetic VirologyGlycobiologyImmunologyPathologyAntiviral Drug	2022	14
SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines Olga A. Smirnova, Olga N. Ivanova, Irina T. Fedyakina, Cancers Productive InfectionViral PersistenceNeurovirologySars-cov-2 EstablishesViral Pathogenesis	2023	14
Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus Anastasia Nikitina, Anastasiya V. Lipatova, Anton O. Goncharov, International Journal of Molecular Sciences Viral PathogenesisImmunologyPathologyImmunotherapyCancer Biology	2022	11

Page 1